• Je něco špatně v tomto záznamu ?

DHA-mediated enhancement of TRAIL-induced apoptosis in colon cancer cells is associated with engagement of mitochondria and specific alterations in sphingolipid metabolism

B. Skender, J. Hofmanová, J. Slavík, I. Jelínková, M. Machala, MP. Moyer, A. Kozubík, A. Hyršlová Vaculová,

. 2014 ; 1841 (9) : 1308-17.

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14074140

Docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid present in fish oil, may exert cytotoxic and/or cytostatic effects on colon cancer cells when applied individually or in combination with some anticancer drugs. Here we demonstrate a selective ability of subtoxic doses of DHA to enhance antiproliferative and apoptotic effects of clinically useful cytokine TRAIL (tumor necrosis factor-related apoptosis inducing ligand) in cancer but not normal human colon cells. DHA-mediated stimulation of TRAIL-induced apoptosis was associated with extensive engagement of mitochondrial pathway (Bax/Bak activation, drop of mitochondrial membrane potential, cytochrome c release), activation of endoplasmic reticulum stress response (CHOP upregulation, changes in PERK level), decrease of cellular inhibitor of apoptosis protein (XIAP, cIAP1) levels and significant changes in sphingolipid metabolism (intracellular levels of ceramides, hexosyl ceramides, sphingomyelines, sphingosines; HPLC/MS/MS). Interestingly, we found significant differences in representation of various classes of ceramides (especially C16:0, C24:1) between the cancer and normal colon cells treated with DHA and TRAIL, and suggested their potential role in the regulation of the cell response to the drug combination. These study outcomes highlight the potential of DHA for a new combination therapy with TRAIL for selective elimination of colon cancer cells via simultaneous targeting of multiple steps in apoptotic pathways.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14074140
003      
CZ-PrNML
005      
20141007110216.0
007      
ta
008      
141006s2014 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bbalip.2014.06.005 $2 doi
035    __
$a (PubMed)24953781
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Skender, Belma $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
245    10
$a DHA-mediated enhancement of TRAIL-induced apoptosis in colon cancer cells is associated with engagement of mitochondria and specific alterations in sphingolipid metabolism / $c B. Skender, J. Hofmanová, J. Slavík, I. Jelínková, M. Machala, MP. Moyer, A. Kozubík, A. Hyršlová Vaculová,
520    9_
$a Docosahexaenoic acid (DHA), an n-3 polyunsaturated fatty acid present in fish oil, may exert cytotoxic and/or cytostatic effects on colon cancer cells when applied individually or in combination with some anticancer drugs. Here we demonstrate a selective ability of subtoxic doses of DHA to enhance antiproliferative and apoptotic effects of clinically useful cytokine TRAIL (tumor necrosis factor-related apoptosis inducing ligand) in cancer but not normal human colon cells. DHA-mediated stimulation of TRAIL-induced apoptosis was associated with extensive engagement of mitochondrial pathway (Bax/Bak activation, drop of mitochondrial membrane potential, cytochrome c release), activation of endoplasmic reticulum stress response (CHOP upregulation, changes in PERK level), decrease of cellular inhibitor of apoptosis protein (XIAP, cIAP1) levels and significant changes in sphingolipid metabolism (intracellular levels of ceramides, hexosyl ceramides, sphingomyelines, sphingosines; HPLC/MS/MS). Interestingly, we found significant differences in representation of various classes of ceramides (especially C16:0, C24:1) between the cancer and normal colon cells treated with DHA and TRAIL, and suggested their potential role in the regulation of the cell response to the drug combination. These study outcomes highlight the potential of DHA for a new combination therapy with TRAIL for selective elimination of colon cancer cells via simultaneous targeting of multiple steps in apoptotic pathways.
650    _2
$a adenokarcinom $x genetika $x metabolismus $x patologie $7 D000230
650    _2
$a apoptóza $x účinky léků $x genetika $7 D017209
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a nádory tračníku $x genetika $x metabolismus $x patologie $7 D003110
650    _2
$a cytochromy c $x sekrece $7 D045304
650    _2
$a kyseliny dokosahexaenové $x farmakologie $7 D004281
650    _2
$a synergismus léků $7 D004357
650    _2
$a stres endoplazmatického retikula $x účinky léků $7 D059865
650    12
$a regulace genové exprese u nádorů $7 D015972
650    _2
$a lidé $7 D006801
650    _2
$a inhibitory apoptózy $7 D051034
650    _2
$a membránový potenciál mitochondrií $x účinky léků $7 D053078
650    _2
$a mitochondrie $x účinky léků $x metabolismus $7 D008928
650    _2
$a signální transdukce $7 D015398
650    _2
$a sfingolipidy $x chemie $x klasifikace $x metabolismus $7 D013107
650    _2
$a protein TRAIL $x farmakologie $7 D053221
650    _2
$a transkripční faktor CHOP $x genetika $x metabolismus $7 D051742
650    _2
$a X-vázaný inhibitor apoptózy $x genetika $x metabolismus $7 D051636
650    _2
$a protein Bak $x genetika $x metabolismus $7 D050998
650    _2
$a protein X asociovaný s bcl-2 $x genetika $x metabolismus $7 D051028
650    _2
$a kinasa eIF-2 $x genetika $x metabolismus $7 D019892
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hofmanová, Jiřina $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Slavík, Josef $u Department of Toxicology, Pharmacology and Immunotherapy, Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Jelínková, Iva $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Machala, Miroslav $u Department of Toxicology, Pharmacology and Immunotherapy, Veterinary Research Institute, Brno, Czech Republic.
700    1_
$a Moyer, Mary Pat $u INCELL Corporation LLC, San Antonio, TX, USA.
700    1_
$a Kozubík, Alois $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic; Department of Animal Physiology and Immunology, Institute of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Hyršlová Vaculová, Alena $u Department of Cytokinetics, Institute of Biophysics, Academy of Sciences of the Czech Republic, v.v.i., Brno, Czech Republic. Electronic address: vaculova@ibp.cz.
773    0_
$w MED00009314 $t Biochimica et biophysica acta $x 0006-3002 $g Roč. 1841, č. 9 (2014), s. 1308-17
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24953781 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20141006 $b ABA008
991    __
$a 20141007110654 $b ABA008
999    __
$a ok $b bmc $g 1042023 $s 873052
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 1841 $c 9 $d 1308-17 $i 0006-3002 $m Biochimica et biophysica acta $n Biochim Biophys Acta $x MED00009314
LZP    __
$a Pubmed-20141006

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace